193 related articles for article (PubMed ID: 33830648)
1. Adipose-derived mesenchymal stem cells induced PAX8 promotes ovarian cancer cell growth by stabilizing TAZ protein.
Chu Y; Zhu C; Wang Q; Liu M; Wan W; Zhou J; Han R; Yang J; Luo W; Liu C; Zhou H; Li M; Yu F; Ye Y
J Cell Mol Med; 2021 May; 25(9):4434-4443. PubMed ID: 33830648
[TBL] [Abstract][Full Text] [Related]
2. Loss of PAX8 in high-grade serous ovarian cancer reduces cell survival despite unique modes of action in the fallopian tube and ovarian surface epithelium.
Rodgers LH; Ó hAinmhire E; Young AN; Burdette JE
Oncotarget; 2016 May; 7(22):32785-95. PubMed ID: 27129161
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological activation of TAZ enhances osteogenic differentiation and bone formation of adipose-derived stem cells.
Zhu Y; Wu Y; Cheng J; Wang Q; Li Z; Wang Y; Wang D; Wang H; Zhang W; Ye J; Jiang H; Wang L
Stem Cell Res Ther; 2018 Mar; 9(1):53. PubMed ID: 29514703
[TBL] [Abstract][Full Text] [Related]
4. PAX8 and MECOM are interaction partners driving ovarian cancer.
Bleu M; Mermet-Meillon F; Apfel V; Barys L; Holzer L; Bachmann Salvy M; Lopes R; Amorim Monteiro Barbosa I; Delmas C; Hinniger A; Chau S; Kaufmann M; Haenni S; Berneiser K; Wahle M; Moravec I; Vissières A; Poetsch T; Ahrné E; Carte N; Voshol J; Bechter E; Hamon J; Meyerhofer M; Erdmann D; Fischer M; Stachyra T; Freuler F; Gutmann S; Fernández C; Schmelzle T; Naumann U; Roma G; Lawrenson K; Nieto-Oberhuber C; Cobos-Correa A; Ferretti S; Schübeler D; Galli GG
Nat Commun; 2021 Apr; 12(1):2442. PubMed ID: 33903593
[TBL] [Abstract][Full Text] [Related]
5. The metastatic phenotype shift toward myofibroblast of adipose-derived mesenchymal stem cells promotes ovarian cancer progression.
Tang H; Chu Y; Huang Z; Cai J; Wang Z
Carcinogenesis; 2020 Apr; 41(2):182-193. PubMed ID: 31046126
[TBL] [Abstract][Full Text] [Related]
6. A role for PAX8 in the tumorigenic phenotype of ovarian cancer cells.
Di Palma T; Lucci V; de Cristofaro T; Filippone MG; Zannini M
BMC Cancer; 2014 Apr; 14():292. PubMed ID: 24766781
[TBL] [Abstract][Full Text] [Related]
7. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma].
Mao YN; Zeng LX; Li YH; Liu YZ; Wu JY; Li L; Wang Q
Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):687-696. PubMed ID: 29060967
[No Abstract] [Full Text] [Related]
8. Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma.
de Cristofaro T; Di Palma T; Soriano AA; Monticelli A; Affinito O; Cocozza S; Zannini M
Oncotarget; 2016 Jul; 7(27):41929-41947. PubMed ID: 27259239
[TBL] [Abstract][Full Text] [Related]
9. Adipose-derived mesenchymal stem cells promote cell proliferation and invasion of epithelial ovarian cancer.
Chu Y; Tang H; Guo Y; Guo J; Huang B; Fang F; Cai J; Wang Z
Exp Cell Res; 2015 Sep; 337(1):16-27. PubMed ID: 26209607
[TBL] [Abstract][Full Text] [Related]
10. HOTAIR promotes paclitaxel resistance by regulating CHEK1 in ovarian cancer.
Jiang J; Wang S; Wang Z; Cai J; Han L; Xie L; Han Q; Wang W; Zhang Y; He X; Yang C
Cancer Chemother Pharmacol; 2020 Aug; 86(2):295-305. PubMed ID: 32743678
[TBL] [Abstract][Full Text] [Related]
11. Exosomes from Human Omental Adipose-Derived Mesenchymal Stem Cells Secreted into Ascites Promote Peritoneal Metastasis of Epithelial Ovarian Cancer.
Qu Q; Liu L; Cui Y; Chen Y; Wang Y; Wang Y
Cells; 2022 Oct; 11(21):. PubMed ID: 36359787
[TBL] [Abstract][Full Text] [Related]
12. Adipose-Derived Mesenchymal Stem Cells Enhance Ovarian Cancer Growth and Metastasis by Increasing Thymosin Beta 4X-Linked Expression.
Chu Y; You M; Zhang J; Gao G; Han R; Luo W; Liu T; Zuo J; Wang F
Stem Cells Int; 2019; 2019():9037197. PubMed ID: 31781249
[TBL] [Abstract][Full Text] [Related]
13. A FXYD5/TGF‑β/SMAD positive feedback loop drives epithelial‑to‑mesenchymal transition and promotes tumor growth and metastasis in ovarian cancer.
Bai Y; Li LD; Li J; Chen RF; Yu HL; Sun HF; Wang JY; Lu X
Int J Oncol; 2020 Jan; 56(1):301-314. PubMed ID: 31746425
[TBL] [Abstract][Full Text] [Related]
14. EZH2 activates CHK1 signaling to promote ovarian cancer chemoresistance by maintaining the properties of cancer stem cells.
Wen Y; Hou Y; Yi X; Sun S; Guo J; He X; Li T; Cai J; Wang Z
Theranostics; 2021; 11(4):1795-1813. PubMed ID: 33408782
[No Abstract] [Full Text] [Related]
15. MIEF2 over-expression promotes tumor growth and metastasis through reprogramming of glucose metabolism in ovarian cancer.
Zhao S; Zhang X; Shi Y; Cheng L; Song T; Wu B; Li J; Yang H
J Exp Clin Cancer Res; 2020 Dec; 39(1):286. PubMed ID: 33317572
[TBL] [Abstract][Full Text] [Related]
16. TAZ Induction Directs Differentiation of Thyroid Follicular Cells from Human Embryonic Stem Cells.
Ma R; Morshed SA; Latif R; Davies TF
Thyroid; 2017 Feb; 27(2):292-299. PubMed ID: 27829313
[TBL] [Abstract][Full Text] [Related]
17. Silencing of long noncoding RNA LINC00958 prevents tumor initiation of pancreatic cancer by acting as a sponge of microRNA-330-5p to down-regulate PAX8.
Chen S; Chen JZ; Zhang JQ; Chen HX; Qiu FN; Yan ML; Tian YF; Peng CH; Shen BY; Chen YL; Wang YD
Cancer Lett; 2019 Apr; 446():49-61. PubMed ID: 30639194
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA TC0101441 induces epithelial-mesenchymal transition in epithelial ovarian cancer metastasis by downregulating KiSS1.
Qiu JJ; Lin XJ; Tang XY; Zheng TT; Zhang XY; Hua KQ
Int J Cancer; 2020 May; 146(9):2588-2598. PubMed ID: 31577838
[TBL] [Abstract][Full Text] [Related]
19. Resistin promotes cardiac homing of mesenchymal stem cells and functional recovery after myocardial ischemia-reperfusion via the ERK1/2-MMP-9 pathway.
He Y; Guo Y; Xia Y; Guo Y; Wang R; Zhang F; Guo L; Liu Y; Yin T; Gao C; Gao E; Li C; Wang S; Zhang L; Yan W; Tao L
Am J Physiol Heart Circ Physiol; 2019 Jan; 316(1):H233-H244. PubMed ID: 30412442
[TBL] [Abstract][Full Text] [Related]
20. A novel role for microRNA-129-5p in inhibiting ovarian cancer cell proliferation and survival via direct suppression of transcriptional co-activators YAP and TAZ.
Tan G; Cao X; Dai Q; Zhang B; Huang J; Xiong S; Zhang Yy; Chen W; Yang J; Li H
Oncotarget; 2015 Apr; 6(11):8676-86. PubMed ID: 25895125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]